Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

The Living Guidelines: STEMI

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Pharmacotherapy

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin ^[1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

The living guidelines

The Living Guidelines: STEMI

Pharmacotherapy

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin [1]

CLASS I

CLASS IIa

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel [1]

CLASS I

CLASS IIa

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin [1]

CLASS I

Recommendations for Beta Blocker Therapy [1]

CLASS I

CLASS IIa

CLASS III

Recommendations for ACE Inhibitors Therapy

CLASS I

CLASS IIa

Recommendations for Angiotensin Receptor Blockers Therapy

CLASS I [1]

CLASS IIb [1]

Recommendations for Aldosterone Blockers Therapy

CLASS I [1]

Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System

CLASS I [1]

CLASS IIa [1]

CLASS IIb [1]

Recommendations for Influenza Vaccination [1]

CLASS I

Reperfusion

Primary Invasive or Pharmacological Approach [1]

CLASS I

Facilitated PCI [1]

CLASS IIb

CLASS III

Immediate (or Emergency) Invasive Strategy and Rescue PCI [1]

Class I

Class IIa

Class IIb

Class III

PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion [1]

Class IIb

Class III

Anticoagulants as Ancillary Therapy [1]

Class I

Anticoagulants for STEMI patients who do not undergo reperfusion therapy [1]

Class IIa

Class III

Thienopyridines [1]

Class I

Class IIa

Reference

The Living Guidelines: UA/NSTEMI

The Living Guidelines: Chronic Stable Angina Pectoris

The Living Guidelines: Percutaneous Coronary Interventions

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

Recommendations for pharmacological rate control during atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for preventing thromboembolism [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for pharmacological cardioversion of atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter [1]

Class I

Class IIa

Class III

Recommendation for pharmacological enhancement of direct-current cardioversion [1]

Class IIa

Class IIb

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion [1]

Class I

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin ^[1]

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel ^[1]

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin ^[1]

Recommendations for Beta Blocker Therapy ^[1]

CLASS I ^[1]

CLASS IIb ^[1]

CLASS I ^[1]

CLASS I ^[1]

CLASS IIa ^[1]

CLASS IIb ^[1]

Recommendations for Influenza Vaccination ^[1]

Primary Invasive or Pharmacological Approach ^[1]

Facilitated PCI ^[1]

Immediate (or Emergency) Invasive Strategy and Rescue PCI ^[1]

PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion ^[1]

Anticoagulants as Ancillary Therapy ^[1]

Anticoagulants for STEMI patients who do not undergo reperfusion therapy ^[1]

Thienopyridines ^[1]

Recommendations for pharmacological rate control during atrial fibrillation ^[1]

Recommendations for preventing thromboembolism ^[1]

Recommendations for pharmacological cardioversion of atrial fibrillation ^[1]

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter ^[1]

Recommendation for pharmacological enhancement of direct-current cardioversion ^[1]

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion ^[1]

Recommendations for maintenance of sinus rhythm ^[1]

Recommendations for patients with postoperative atrial fibrillation ^[1]

Recommendations for patients with acute myocardial infarction ^[1]

Recommendations for patients with Wolff Parkinson White syndrome (WPW) ^[1]

Recommendations for patients with hyperthyroidism ^[1]

Recommendations for pregnant patients ^[1]

Recommendations for patients with Hypertrophic Cardiomyopathy ^[1]

Recommendations for patients with Pulmonary Hypertension ^[1]